Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 403.76%60.2K | 44.7K | 12.02K | 32.05K | 12.14K | 11.95K | 0 | 0 | 0 | 0 |
| Gross profit | -403.76%-60.2K | -44.7K | -12.02K | -32.05K | -12.14K | -11.95K | 0 | 0 | 0 | 0 |
| Operating expense | 9.54%701.67K | 107.01%1.27M | 127.09%440.32K | 93.56%2.15M | 53.67%702.39K | 72.31%640.55K | 216.10%611.33K | 121.39%193.9K | -0.22%1.11M | 174.98%457.08K |
| Selling and administrative expenses | 46.53%510.07K | 0.51%605.56K | 121.01%403.1K | 80.76%1.78M | 44.75%649.2K | 15.67%348.11K | 278.75%602.47K | 135.57%182.39K | -8.09%985.92K | 184.36%448.49K |
| -Selling and marketing expense | 10,001.49%20.41K | -55.37%19.08K | 323.92%17.37K | -44.38%47.65K | -99.19%610 | -94.49%202 | 1,651.84%42.75K | -6.78%4.1K | -57.28%85.67K | 221.38%75.17K |
| -General and administrative expense | 40.75%489.66K | 4.78%586.48K | 116.34%385.73K | 92.67%1.73M | 73.74%648.59K | 17.03%347.9K | 257.36%559.73K | 144.14%178.29K | 3.22%900.25K | 177.91%373.32K |
| Research and development costs | --2.49K | --190K | ---- | --0 | --0 | --0 | --0 | ---- | --67.55K | --0 |
| Other operating expenses | -35.33%189.11K | 5,204.33%469.96K | 223.50%37.23K | 549.59%366K | 518.98%53.19K | 1,922.32%292.45K | -61.70%8.86K | 13.27%11.51K | 42.63%56.34K | 1.05%8.59K |
| Operating profit | -16.76%-761.87K | -114.32%-1.31M | -133.29%-452.34K | -96.45%-2.18M | -56.32%-714.52K | -75.52%-652.5K | -216.10%-611.33K | -121.39%-193.9K | 0.22%-1.11M | -174.98%-457.08K |
| Net non-operating interest income (expenses) | 80.04%-2.23K | 10.93%-11.67K | -116.15%-4.74K | -144.57%-30.72K | 66.03%-4.27K | -11.15K | -13.11K | -2.19K | -12.56K | -12.56K |
| Non-operating interest expense | --441 | -10.93%11.67K | 89.01%4.14K | 293.36%20.27K | 293.36%20.27K | --0 | --13.11K | --2.19K | --5.15K | --5.15K |
| Total other finance cost | -84.00%1.79K | ---- | --595 | 41.09%10.45K | ---16K | --11.15K | ---- | ---- | --7.41K | ---- |
| Other net income (expenses) | -261,740.37%-570.38K | -8.5K | 6,787.83%243.97K | 55.80%-1.53M | 28.88%-1.53M | 100.02%218 | -885.95%-3.65K | -75.70%-3.47M | -85.02%-2.15M | |
| Gain on sale of security | -185.91%-2.73K | ---8.5K | 66.09%-1.24K | -573.66%-7.27K | ---6.8K | --3.18K | ---- | -7,396.00%-3.65K | 141.82%1.53K | --0 |
| Special income (charges) | -8,849.14%-567.64K | ---- | ---- | 64.64%-1.23M | 42.65%-1.23M | 100.49%6.49K | --0 | --0 | -74.34%-3.47M | -81.83%-2.15M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 172.65%3.47M | 81.83%2.15M |
| -Less:Other special charges | 8,849.14%567.64K | ---- | ---- | --1.28M | --1.28M | ---6.49K | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Gain on sale of business | ---- | ---- | ---- | --50K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---266.31K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -101.15%-1.33M | -113.05%-1.33M | -6.69%-213.11K | 18.42%-3.74M | 14.18%-2.25M | 60.72%-663.44K | -225.01%-624.44K | -127.09%-199.74K | -48.73%-4.59M | -97.23%-2.62M |
| Income tax | 0 | 0 | 0 | 99.65%-17 | 0 | 0 | 0 | -17 | -4.81K | -4.81K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -101.15%-1.33M | -113.05%-1.33M | -6.70%-213.11K | 18.34%-3.74M | 14.03%-2.25M | 60.72%-663.44K | -225.01%-624.44K | -127.07%-199.72K | -48.58%-4.58M | -96.87%-2.61M |
| Net income continuous operations | -101.15%-1.33M | -113.05%-1.33M | -6.70%-213.11K | 18.34%-3.74M | 14.03%-2.25M | 60.72%-663.44K | -225.01%-624.44K | -127.07%-199.72K | -48.58%-4.58M | -96.87%-2.61M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -101.15%-1.33M | -113.05%-1.33M | -6.70%-213.11K | 18.34%-3.74M | 14.03%-2.25M | 60.72%-663.44K | -225.01%-624.44K | -127.07%-199.72K | -48.58%-4.58M | -96.87%-2.61M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -101.15%-1.33M | -113.05%-1.33M | -6.70%-213.11K | 18.34%-3.74M | 14.03%-2.25M | 60.72%-663.44K | -225.01%-624.44K | -127.07%-199.72K | -48.58%-4.58M | -96.87%-2.61M |
| Diluted earnings per share | 40.30%-0.4 | 50.00%-0.4 | 0 | 61.82%-4.2 | 60.31%-2.27 | 83.08%-0.67 | 59.60%-0.8 | -74.46%-0.4 | 7.41%-11 | -8.33%-5.72 |
| Basic earnings per share | 40.30%-0.4 | 50.00%-0.4 | 0 | 61.82%-4.2 | 60.31%-2.27 | 83.08%-0.67 | 59.60%-0.8 | -74.46%-0.4 | 7.41%-11 | -8.33%-5.72 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.